These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 699758)

  • 21. The hypotensive effect of a single daily dose of labetalol: a preliminary study.
    Rossi A; Ziacchi V; Lomanto B
    Int J Clin Pharmacol Ther Toxicol; 1982 Sep; 20(9):438-45. PubMed ID: 6754634
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A multicentre study of labetalol in hypertension. New Zealand Hypertension Study Group.
    N Z Med J; 1981 Apr; 93(681):215-8. PubMed ID: 7017511
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Treatment of arterial hypertension in pregnancy with an alpha-beta blocker. 58 Cases treated with labetalol].
    Gérard J; Blazquez G; Mounac M; Giraud P; Jeuffroy A; Lardoux H
    Rev Fr Gynecol Obstet; 1984 Nov; 79(11):713-7. PubMed ID: 6152500
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Blood pressure, plasma volume, extracellular volume and glomerular filtration rate during treatment with labetalol in essential hypertension.
    Rasmussen S; Nielsen PE
    Postgrad Med J; 1980; 56 Suppl 2():33-6. PubMed ID: 7433340
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Labetalol in the treatment of resistant hypertension].
    Krechnáková A; Danĕková H; Nandoryová M; Niederland TR
    Vnitr Lek; 1981 Jul; 27(7):660-6. PubMed ID: 7303500
    [No Abstract]   [Full Text] [Related]  

  • 26. Labetalol.
    Carter BL
    Drug Intell Clin Pharm; 1983 Oct; 17(10):704-12. PubMed ID: 6354658
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A five-year study of labetalol in hypertension.
    Kane J; Gregg I; Stephens MD
    Practitioner; 1981 Jan; 225(1351):97-8, 100. PubMed ID: 7220466
    [No Abstract]   [Full Text] [Related]  

  • 28. Proceedings of the Third Symposium on Labetalol.
    Br J Clin Pharmacol; 1982 Jun; 13(1 Suppl):1S-141S. PubMed ID: 7093091
    [No Abstract]   [Full Text] [Related]  

  • 29. Experience with labetalol in hypertension.
    Bolli P; Waal-Manning J; Wood AJ; Simpson FO
    Br J Clin Pharmacol; 1976 Aug; 3(4 Suppl 3):765-71. PubMed ID: 791330
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Treatment of acute pregnancy-related hypertension: labetalol and hydralazine compared.
    Walker JJ; Greer I; Calder AA
    Postgrad Med J; 1983; 59 Suppl 3():168-70. PubMed ID: 6647203
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Labetalol in hypertensive emergencies.
    Br Med J; 1978 Sep; 2(6139):772. PubMed ID: 698718
    [No Abstract]   [Full Text] [Related]  

  • 32. [Labetalol: a new alpha/beta-adrenergic receptor blocking agent].
    Gyimesi A; Hanyecz V; Pocsay G; Iványi J
    Orv Hetil; 1981 Nov; 122(46):2831-4. PubMed ID: 7033885
    [No Abstract]   [Full Text] [Related]  

  • 33. [Open clinical trial of labetalol in ambulatory patients with arterial hypertension].
    Baratta L; Florio P; Guerrieri P; Lanciotti G; Mastrocola C; Petrosillo N; Scarfò G; Avella A
    Clin Ter; 1981 Oct; 99(2):139-47. PubMed ID: 7032831
    [No Abstract]   [Full Text] [Related]  

  • 34. [Treatment of arterial hypertension in the pregnant woman with labetalol. A propos of 24 cases].
    Dubois D; Petitcolas J; Temperville B; Klepper A; Leboullenger P
    J Gynecol Obstet Biol Reprod (Paris); 1984; 13(6):691-700. PubMed ID: 6520355
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Double-blind trial of labetalol.
    Kane J; Gregg I; Richards DA
    Br J Clin Pharmacol; 1976 Aug; 3(4 Suppl 3):737-41. PubMed ID: 791329
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Labetalol: a field study in essential hypertension (author's transl)].
    Greminger P; Minder F; Schärer HU
    Schweiz Rundsch Med Prax; 1982 Feb; 71(8):332-6. PubMed ID: 7041108
    [No Abstract]   [Full Text] [Related]  

  • 37. [Treatment of hypertension by labetalol (author's transl)].
    Sternon J; Melot C; Contu E
    Rev Med Brux; 1980 Nov; 1(9):615-21. PubMed ID: 7455430
    [No Abstract]   [Full Text] [Related]  

  • 38. A controlled comparison of the antihypertensive effects of labetalol and alpha-methyldopa.
    Al-Damluji SF; Al-Khalidi A; Shaarbaf H; Tawfiq NH
    Pharmatherapeutica; 1982; 3(2):133-9. PubMed ID: 7048338
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Side-effects with long-term labetalol: an open study of 251 patients in a single centre.
    Tcherdakoff P
    Pharmatherapeutica; 1983; 3(5):342-8. PubMed ID: 6844370
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Clinical and polygraphic evaluation of the effects of metoprolol and labetalol in essential arterial hypertension. Comparative study].
    Schirripa V; Attisano N; Sarica G; Grenci G; Martelli G
    Boll Soc Ital Cardiol; 1981; 26(11):1909-16. PubMed ID: 7349263
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.